A83/100

Is Steris (STE) a risky stock?

Sector: Health Care Price: $211.98 Composite: 83/100

As of July 21, 2026, Clavix grades Steris (STE) A for risk, a composite score of 83 out of 100 on an A+ to F scale, which puts STE in the "low risk" band. The grade is a risk read for educational purposes, not a buy or sell recommendation.

Grade as of July 21, 2026. Clavix regrades every trading day.

The five risk dimensions behind STE's grade

Each Clavix grade is a composite of five independent reads. Higher is safer. Here is how STE scores on each, as of July 21, 2026.

Financial healthbalance sheet, margins, cash flow
83
News sentimentscored, sourced recent coverage
56
Macro exposuresensitivity to rates, dollar, oil
80
Sector resiliencestrength vs the broad market
59
Price stabilitydrawdown and volatility
49

What's moving STE's risk right now

Company-specific signals Clavix flags behind STE's current grade, drawn from recent news and filings as of July 21, 2026.

Demand · mixed signal

Investor Bessemer Group added to its STE stake, signaling continued institutional confidence. At the same time, Swedbank AB trimmed its holding by 15.9% in the first quarter.

What a A grade means

On the Clavix A+ to F scale, STE's composite of 83 falls in the A band (80–100), read as "low risk." The scale is fixed, so the meaning never moves.

A+AA-B+BB-C+CC-D+DD-F
Get Clavix on iPhone → Or grade your whole portfolio free, no account needed.

This page is generated from Clavix's own risk model and is for educational purposes only. It is not investment advice or a recommendation to buy or sell STE or any security. Grades are risk indicators, not predictions of return. Data may be delayed.